FOLLOW US

  • facebook
  • twitter
Wed

March 3, 2026

Health December 22, 2020

President-elect Biden receives COVID-19 vaccine, gives credit to Trump admin.

President-elect Joe Biden received his first dose of the BioNTech-Pfizer COVID-19 vaccine live on television on Monday. Biden said he…

By Dee Dulfo

COVID-19 vaccine booster shots

America December 18, 2020

FDA advisory panel endorses Moderna COVID-19 vaccine for emergency use

Another vaccine for the novel coronavirus is one step closer to be given the green light. This is after a…

By Dee Dulfo

Pfizer-BioNTech COVID-19 vaccine

America December 17, 2020

U.S. officials cite potential challenges in Pfizer’s COVID-19 vaccine production

The U.S. Health and Human Services (HHS) Secretary Alex Azar said authorities and Pfizer Inc (NYSE: PFE) are ramping up efforts…

By Dee Dulfo

America December 3, 2020

COVID-19 vaccination cards to be issued to people who get vaccinated

The U.S. Department of Defense (DOD) on Wednesday provided a preview of COVID-19 vaccination kits and what they look like.…

By Dee Dulfo

COVID-19 vaccine booster shots

America November 22, 2020

AstraZeneca-Oxford COVID-19 vaccine buoys immense hope from emerging countries

The clinical trial successes from pharmaceutical companies Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) on their COVID-19 vaccines gave…

By Dee Dulfo

bitcoin

U.S. News November 19, 2020

Deutsche Bank: investors starting to prefer Bitcoin over gold as hedge against inflation

Analysts from the German-based investment firm Deutsche Bank noted that an increasing number of investors are beginning to prefer bitcoin (BTC)…

By Colby McCoy

Health November 16, 2020

Biden ‘wouldn’t hesitate’ receiving a COVID-19 vaccine, blames Trump for vaccine skepticism

In an ongoing battle against President Donald Trump over a chosen election victor, President-elect Joe Biden said Monday that he…

By Colby McCoy

COVID-19 vaccine booster shots

Business November 16, 2020

Moderna says its COVID-19 vaccine candidate is 94.5 percent effective

Moderna, Inc. (NASDAQ: MRNA) announced that its COVI-19 vaccine candidate is 94.5% effective in preventing the disease based on the…

By Marivic Cabural Summers

Vaccines -FDA-image

Business November 12, 2020

Moderna days away from releasing key COVID-19 vaccine data

The stock price of Moderna (NASDAQ: MRNA) following news that critical COVID-19 vaccine data from late-stage trials would be released in…

By Colby McCoy

Health November 2, 2020

Moderna poised to launch COVID-19 vaccine, raking in $1.1 billion in deposits from governments

Moderna is reportedly making preparations for the launch of its highly anticipated COVID-19 vaccine, raking in $1.1 billion in deposits…

By Colby McCoy

Signup for the USA Herald
exclusive Newsletter